ADO and hepatocellular carcinoma: To confirm how this CD39 (mostly expressed on macrophages)–CD73 (mostly expressed on HCC cells) axis affects the ATP–adenosine pathway in the tumor environment, we then monitored the level of eATP, AMP, and ADO in medium with different conditions.